Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Psoriasis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
160
Start Date:
May 2, 2022
A Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging, Proof-of-concept Trial of BI 730357 Given for 12 Weeks in Patients With Active Psoriatic Arthritis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug, Other
Participants:
40
Start Date:
September 24, 2021
A Phase III Randomized, Double-blind, Placebo Controlled, Multicenter, Bridging Study of Subcutaneous Secukinumab, to Demonstrate Efficacy After Sixteen Weeks of Treatment and to Assess Safety, Tolerability and Long-term Efficacy Follow-up to One Year in Chinese Subjects With Active Psoriatic Arthritis
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Procedure, Drug
Participants:
20
Start Date:
September 2021
Immune Modification of Psoriasis by Selective IL-23 Blockade Using Risankizumab
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
5
Start Date:
August 31, 2021
Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
60
Start Date:
July 27, 2021
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)
Clinical Trial
Status:
Not yet recruiting
Participants:
10
Start Date:
June 2021
Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
76
Start Date:
June 1, 2021
Impact of Acute Cannabis Administration on Pain Symptomology and Inflammatory Markers Among Patients With Rheumatoid or Psoriatic Arthritis
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Other
Participants:
125
Start Date:
May 30, 2021
Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Procedure
Participants:
175
Start Date:
May 1, 2021
Defining the Role of the Skin Microbiome in Vitiligo and Immune-related Adverse Events in Advanced Melanoma Patients Treated With Anti-PD1
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
40
Start Date:
May 2021
Phase IV Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
12
Start Date:
May 2021
A Pilot, Open-Label Study in Subjects With Mild-to-Moderate Plaque Psoriasis to Investigate the Dosing Feasibility, Safety, Tolerability, and Preliminary Efficacy of a Four-Week Multi-dose Regimen of DLX105-DMP Administered to a Target Lesion
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Biological
Participants:
384
Start Date:
April 1, 2021
Adjustable Brodalumab Dosage Regimen Compared With Standard Brodalumab Treatment for 52 Weeks in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
Showing 1-12 of 382
Next